* Creative Medical Technology Holdings Inc reported a quarterly adjusted loss of $1.19 per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of $-5.30. The lone analyst forecast for the quarter was for a loss of $1.13 per share.
* Revenue fell 84.2% to $3.00 thousand from a year ago; analysts expected zero.
* Creative Medical Technology Holdings Inc's reported EPS for the quarter was a loss of $1.19.
* The company reported a quarterly loss of $1.68 million.
* Creative Medical Technology Holdings Inc shares had risen by 12.6% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Creative Medical Technology Holdings Inc is $30.00
This summary was machine generated from LSEG data March 25 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -1.13 -1.19 Missed
Sep. 30 2023 -0.86 -1.02 Missed
Jun. 30 2023 -0.83 -0.78 Beat
Mar. 31 2023 -1.00 -0.70 Beat
Comments